BioTime, Inc. (NYSE: BTX) went down by -3.70% from its latest closing price when compared to the 1-year high value of $2.13, while BTX stocks collected -9.83% of loss with the last five trading sessions.

BioTime, Inc. (NYSE: BTX) Worth an Investment?

BioTime, Inc. (NYSE: BTX), The 36 Months beta value for BTX stocks is at 3.09, while 4 of the analysts out of 5 who provided ratings for BioTime, Inc. stocks as a “buy” while 1 as overweight, 0 rated it as hold and 0 as sell. The average price we get from analysts is $4.20 which is $3.44 above current price. BTX currently has a short float of 7.89% and public float of 125.51M with average trading volume of 1.02M shares.

BTX Market Performance

BTX stocks went down by -9.83% for the week, with the monthly jump of 21.88% and a quarterly performance of 77.47%, while its annual performance rate touched -24.02%. The simple moving average for the period of the last 20 days is 12.43% for BTX stocks with the simple moving average of 3.46% for the last 200 days.

Analysts’ Opinion on BioTime, Inc. (NYSE: BTX)

Many brokerage firms have already submitted their reports for BTX stocks, with H.C. Wainwright repeating the rating for BTX shares by setting it to “Buy”. The predicted price for BTX socks in the upcoming period according to H.C. Wainwright is $4 based on the research report published on February 21, 2019.

Maxim Group, on the other hand, stated in their research note that they expect to see BTX stock at the price of $3. The rating they have provided for BTX stocks is “Buy” according to the report published on January 24, 2019.

Oppenheimer gave “Outperform” rating to BTX stocks, setting the target price at $3.50 in the report published on December 11, 2018.

BTX Stocks 25.50% Far from 50 Day Moving Average

After a stumble in the market that brought BTX to its low price for the period of the last 52 weeks, BioTime, Inc. was unable to take a rebound, for now settling with -26.73% of loss for the given period.

The stock volatility was left at 9.78%, however, within the period of a single month, the volatility rate increased by 8.91%, while the shares surge at the distance of +25.81% for the moving average in the last 20 days. In oppose to the moving average for the last 50 days, trading by +33.33% upper at the present time.

In the course of the last 5 trading sessions, BTX went down by -9.83%, which changed the moving average for the period of 200 days to the total of -37.35% of losses for the stock in comparison to the 20-day moving average settled at $1.40. In addition, BioTime, Inc. saw 70.87% in overturn over the period of a single year with a tendency to cut further gains.

BTX Stock Insider Trading

Reports are indicating that there were more than several insider trading activities at BioTime, Inc. (BTX), starting from ANDREWS DEBORAH J, who bought 1,604 shares at the price of $2.35 back on Sep 11. After this action, Rushing now owns 10,000 shares of BioTime, Inc., valued at $3,769 with the latest closing price.

BTX Stock Fundamentals

The current profitability levels are settled at -3147.39 for the present operating margin and -152.47 for gross margin. The net margin for BioTime, Inc. stands at -3247.88. Total capital return value is set at -34.38, while invested capital returns managed to touch -35.57. Equity return holds the value -39.50%, with -36.80% for asset returns.

Based on BioTime, Inc. (BTX), the company’s capital structure generated 2.41 points for debt to equity in total, while total debt to capital is set at the value of 2.36. Total debt to assets is settled at the value of 2.23 with long-term debt to equity ratio rests at 2.09 and long-term debt to capital is 2.04.

The value for Enterprise to Sales is 135.03 with debt to enterprise value settled at 0.03. The receivables turnover for BioTime, Inc. is 0.42 with the total asset turnover at the value of 0.01. The liquidity ratio also appears to be rather interesting for investors as it stands at 5.34.